SEC 13F Intelligence

Birchview Capital, LP / CMPX

Birchview Capital, LP’s Compass Therapeutics Inc Position

Does Birchview Capital, LP own Compass Therapeutics Inc (CMPX)? Yes — 1.47M shares worth $8M (+4.41% of its 13F portfolio) as of Q1 2026, down from 1.59M shares the prior filed quarter.

Position Value
$8M
Q1 2026
Shares
1.47M
% of Portfolio
+4.41%
Quarters Held
4
currently held

Position History CMPX

Reported value by quarter
Q1 ’25: $45,600Q1 ’25Q3 ’25: $3MQ3 ’25Q4 ’25: $9MQ4 ’25Q1 ’26: $8MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.47M$8M+4.41%
Q4 20251.59M$9M+5.01%
Q3 2025872.9K$3M+2.31%
Q1 202524.0K$45,600+0.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of CMPX.